Dexa/The Proof with Simon Hill

Cutting-Edge Trials

Thomas discusses the potential quick results of new drugs targeting LP levels and the importance of safety data in ongoing trials. Exciting insights into the future of cardiovascular health research.

In this clip
From this podcast
The Proof with Simon Hill
Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring
Related Questions
- What drugs can be used to lower apoB in place of PCSK9 inhibitors?
- Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?